Tapan Chowdhury to buy Square Pharma shares worth Tk40cr
According to a disclosure, the shares will be purchased at the prevailing market price either in the public or block market within the next 30 working days.
Tapan Chowdhury, managing director of Square Pharmaceuticals, has announced his intention to buy 20 lakh shares of the company through the Dhaka Stock Exchange (DSE).
According to a disclosure, the shares will be purchased at the prevailing market price either in the public or block market within the next 30 working days.
Square Pharmaceuticals' shares were trading at Tk199.50 each on the DSE today (5 January). At this price, the total value of the proposed purchase stands at around Tk40 crore.
Market analysts view the move as a positive signal of confidence from the company's top management in Square Pharma's business prospects and long-term growth.
